Thomas Boehm

10PUBLICATIONS
11CO-AUTHORS
AllergyDisease surveillanceMedical biochemistry - inorganic elements and compoundsNanofabrication, growth and self assemblyEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 29, 2025
COVID-19 mRNA-1273 vaccination induced mast cell activation with strongly elevated Th2 cytokines in a systemic mastocytosis patient.

Matthias Weiss-Tessbach, Teresa Haider, Aoife Gowran

|Feb 11, 2025
Nitric oxide is an irreversible human diamine oxidase inhibitor.

Felix Kosta, Elisabeth Gludovacz, Rudolf Figl

|Mar 15, 2023
Simple, fast and inexpensive quantification of glycolate in the urine of patients with primary hyperoxaluria type 1.

Thomas Boehm, Cristina Martin-Higueras, Eva Friesser

|Jun 10, 2022
Nafamostat is a Potent Human Diamine Oxidase Inhibitor Possibly Augmenting Hypersensitivity Reactions during Nafamostat Administration.

Thomas Boehm, Marion Alix, Karin Petroczi

|Mar 18, 2022
Diamine oxidase knockout mice are not hypersensitive to orally or subcutaneously administered histamine.

Matthias Karer, Marlene Rager-Resch, Teresa Haider

|Sep 03, 2021
Heparin-binding motif mutations of human diamine oxidase allow the development of a first-in-class histamine-degrading biopharmaceutical.

Elisabeth Gludovacz, Kornelia Schuetzenberger, Marlene Resch

Pageof 2

Frequent Collaborators

1 joint publications

Elisabeth Gludovacz

1 joint publications

Markus Schosserer

1 joint publications

Jürgen Pollheimer

1 joint publications

Matthias Weiss-Tessbach